PR

Pudhucode Radhakrishnan Kannan

Active Director Director DIN 03435209
DIN 03435209 First appointment Feb 2011 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Current companies 8 active board seats
Past companies 55 historical roles
Total affiliations 63 Since Feb 2011
Shareholding value •••• Premium profile

About Pudhucode Radhakrishnan Kannan

Data last updated:

Pudhucode Radhakrishnan Kannan is a Director at Tenshi Pharmaceuticals Private Limited (since 2024), Director at Aurore Life Sciences Private Limited (since 2025) and Nominee Director at Naari Pharma Private Limited (since 2025), and holds 5 more current directorships. The companies operate in Financial Services, Pharma and Telecom. The 5 current companies with reported revenue have a combined latest revenue of ₹1,776 Cr; the largest is Tenshi Pharmaceuticals Private Limited at ₹1,071 Cr (FY 2024). Earlier, Pudhucode Radhakrishnan Kannan was a Whole-Time Director at Onesource Specialty Pharma Limited (2017–2024) and Director at Biolexis Private Limited (2022–2024) and 53 more.

DIN 03435209
Primary Designation Director
Industry Financial Services
First Appointment 09 Feb 2011
Oldest Company Age 48 yrs
Largest company Tenshi Pharmaceuticals Private Limited · ₹1,071 Cr (FY 2024)
Combined revenue ₹1,776 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jun 20242016₹1,071 Cr (FY 2024)Active
Aurore Life Sciences Private Limited U74999MH2016PTC371990
Director13 Jan 20252016₹471 Cr (FY 2025)Active
Naari Pharma Private Limited U74899KA1978PTC142872
Nominee Director24 Jul 20251978₹136 Cr (FY 2025)Active
Nominee Director30 Sep 20242007₹81.13 Cr (FY 2025)Active
Brooks Steriscience Limited U24297MH2020PLC465110
Director01 Jan 20252020₹16.45 Cr (FY 2023)Active
Dvise Pharma Tech Private Limited U21001KA2026PTC214441
Director19 Jan 20262026Active
Dvise Medtech Private Limited U21000KA2025PTC206269
Director05 Aug 20252025Active
Serovia Pharma Private Limited U21001KA2025PTC205529
Director19 Jul 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Onesource Specialty Pharma Limited L74140MH2007PLC432497
Whole-Time Director25 Mar 20172007₹1,437 Cr (FY 2026)Active
Biolexis Private Limited U24239KA2022PTC156696
Director17 Jan 20222022₹1.87 Cr (FY 2025)Active
Designated Partner09 Feb 20112011₹21.31 Cr (FY 2020)Active
Sequent Research Limited U24232TS2007PLC196886
Director08 Jul 20152007₹9.52 Cr (FY 2025)Amalgamated
Chayadeep Properties Private Limited U45203KA2003PTC094179
Director20 Aug 20122003₹16.74 Cr (FY 2025)Active
Skanray Healthcare Private Limited U85100KA2010PTC054613
Director31 Mar 20122010Amalgamated
Agnus Holdings Private Limited U33111KA2002PTC094085
Director02 Apr 20122002₹5.03 Cr (FY 2025)Active
Karuna Ventures Private Limited U74110KA2009PTC050575
Director02 Apr 20122009₹1.92 Cr (FY 2025)Active
Designated Partner19 Jun 20152015Strike Off
Santo Properties Private Limited U70102MH2011PTC224475
Director02 Apr 20122011Strike Off
Quadgen Networks Private Limited U72200KA2016PTC093729
Alternate Director01 Mar 20182016₹12.50 Cr (FY 2017)Amalgamated
Bluskills Education Private Limited U74999KA2017PTC100466
Director13 Feb 20172017₹34.7 Lakh (FY 2018)Dissolved (Liquidated)

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Pudhucode Radhakrishnan Kannan

NameDINCompanyDesignation
Shridhara Kela02592314Tenshi Pharmaceuticals Private LimitedDirector
Dilip Murthy Buddha11100973Aurore Life Sciences Private LimitedNominee Director
Pooja ToshniwalAurore Life Sciences Private LimitedCompany Secretary
Rajender Juvvadi Rao00083540Aurore Life Sciences Private LimitedManaging Director
Suresh Mudhunuri08077539Aurore Life Sciences Private LimitedNominee Director
Deepak Komaregowda03298261Naari Pharma Private LimitedNominee Director
Hermann Osterwald06710258Naari Pharma Private LimitedNominee Director
Prashanth BhaskarNaari Pharma Private LimitedCfo
Prithipal Singh Kochhar01052194Naari Pharma Private LimitedWhole-Time Director
Arogyaswami Joseph Paulraj00303097Quadgen Wireless Solutions Private LimitedDirector
Chunduru Sambasiva Rao01757876Quadgen Wireless Solutions Private LimitedDirector
Palepu Sudhir Rao00018213Quadgen Wireless Solutions Private LimitedNominee Director
Shradha MatoliaQuadgen Wireless Solutions Private LimitedCompany Secretary
Srikalahasti Mallikarjunarao Vagvala01868948Quadgen Wireless Solutions Private LimitedDirector
Atul Ranchal01998361Brooks Steriscience LimitedDirector
Chamarahalli Sundhar Krishna Iyer07181267Brooks Steriscience LimitedDirector
Chhitiz Saraogi10626776Brooks Steriscience LimitedAdditional Director
Santosh Kumar Khare09244648Brooks Steriscience LimitedWhole-Time Director
Ankit Gupta08015587Dvise Pharma Tech Private Limited , Dvise Medtech Private Limited and 1 moreDirector
Dhriti Sethi11313347Serovia Pharma Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Chayadeep Pharma Alliance Llp
Santo Properties Private Limited
Quadgen Networks Private Limited
Bluskills Education Private Limited
Premium access

Shareholding and investment profile for Pudhucode Radhakrishnan Kannan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pudhucode Radhakrishnan Kannan

Pudhucode Radhakrishnan Kannan currently holds 8 directorships: Tenshi Pharmaceuticals Private Limited (Director, since 17 Jun 2024, revenue ₹1,071 Cr (FY 2024)); Aurore Life Sciences Private Limited (Director, since 13 Jan 2025, revenue ₹471 Cr (FY 2025)); Naari Pharma Private Limited (Nominee Director, since 24 Jul 2025, revenue ₹136 Cr (FY 2025)); Quadgen Wireless Solutions Private Limited (Nominee Director, since 30 Sep 2024, revenue ₹81.13 Cr (FY 2025)); Brooks Steriscience Limited (Director, since 01 Jan 2025, revenue ₹16.45 Cr (FY 2023)); and 3 more.

Pudhucode Radhakrishnan Kannan was first appointed on 09 Feb 2011 as Designated Partner at Pronomz Ventures Llp. The most recent appointment on record is 19 Jan 2026 at Dvise Pharma Tech Private Limited.

The 5 current companies of Pudhucode Radhakrishnan Kannan that report revenue have a combined latest revenue of ₹1,776 Cr: Tenshi Pharmaceuticals Private Limited ₹1,071 Cr (FY 2024); Aurore Life Sciences Private Limited ₹471 Cr (FY 2025); Naari Pharma Private Limited ₹136 Cr (FY 2025); Quadgen Wireless Solutions Private Limited ₹81.13 Cr (FY 2025); Brooks Steriscience Limited ₹16.45 Cr (FY 2023).

Pudhucode Radhakrishnan Kannan held 55 earlier board appointments: Onesource Specialty Pharma Limited (Whole-Time Director, 25 Mar 2017 to 17 Jun 2024); Biolexis Private Limited (Director, 17 Jan 2022 to 17 Jun 2024); Pronomz Ventures Llp (Designated Partner, 09 Feb 2011 to 10 Jan 2021); Sequent Research Limited (Director, 08 Jul 2015 to 24 May 2017); Chayadeep Properties Private Limited (Director, 20 Aug 2012 to 27 Feb 2017); and 50 more.

The current boards of Pudhucode Radhakrishnan Kannan's companies include Shridhara Kela (Tenshi Pharmaceuticals Private Limited), Dilip Murthy Buddha (Aurore Life Sciences Private Limited), Pooja Toshniwal (Aurore Life Sciences Private Limited), Rajender Juvvadi Rao (Aurore Life Sciences Private Limited), Suresh Mudhunuri (Aurore Life Sciences Private Limited), Deepak Komaregowda (Naari Pharma Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available